CN113678922A - 一种人参枸杞黄精茶配方及其制备方法 - Google Patents
一种人参枸杞黄精茶配方及其制备方法 Download PDFInfo
- Publication number
- CN113678922A CN113678922A CN202010427281.4A CN202010427281A CN113678922A CN 113678922 A CN113678922 A CN 113678922A CN 202010427281 A CN202010427281 A CN 202010427281A CN 113678922 A CN113678922 A CN 113678922A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw materials
- ginseng
- preparation
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 33
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 33
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 235000017784 Mespilus germanica Nutrition 0.000 title claims abstract description 18
- 235000000560 Mimusops elengi Nutrition 0.000 title claims abstract description 18
- 235000007837 Vangueria infausta Nutrition 0.000 title claims abstract description 18
- 244000182216 Mimusops elengi Species 0.000 title claims abstract 9
- 238000009472 formulation Methods 0.000 title description 2
- 244000131316 Panax pseudoginseng Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 title 1
- 239000002994 raw material Substances 0.000 claims abstract description 48
- 241001122767 Theaceae Species 0.000 claims abstract description 40
- 240000004371 Panax ginseng Species 0.000 claims abstract description 32
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 26
- 240000001548 Camellia japonica Species 0.000 claims abstract description 15
- 235000018597 common camellia Nutrition 0.000 claims abstract description 15
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 13
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 13
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 13
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 241000234435 Lilium Species 0.000 claims abstract description 13
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 13
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 241000287127 Passeridae Species 0.000 claims abstract description 13
- 241000220317 Rosa Species 0.000 claims abstract description 13
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 13
- 241000572565 Alpinia oxyphylla Species 0.000 claims abstract description 12
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 12
- 240000005001 Paeonia suffruticosa Species 0.000 claims abstract description 12
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims abstract description 12
- 241001633680 Polygonatum odoratum Species 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 12
- 235000011477 liquorice Nutrition 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims description 14
- 244000007853 Sarothamnus scoparius Species 0.000 claims description 13
- 241000245665 Taraxacum Species 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000011265 semifinished product Substances 0.000 claims description 10
- 235000019640 taste Nutrition 0.000 claims description 10
- 230000035622 drinking Effects 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 238000009461 vacuum packaging Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 2
- 244000301850 Cupressus sempervirens Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 30
- 210000004072 lung Anatomy 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 17
- 206010011224 Cough Diseases 0.000 abstract description 14
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 210000002784 stomach Anatomy 0.000 abstract description 13
- 230000008961 swelling Effects 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 4
- 230000005906 menstruation Effects 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 13
- 240000002624 Mespilus germanica Species 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 241000218691 Cupressaceae Species 0.000 description 7
- 240000001972 Gardenia jasminoides Species 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 230000035922 thirst Effects 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 235000019605 sweet taste sensations Nutrition 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 240000003864 Ulex europaeus Species 0.000 description 4
- 235000010730 Ulex europaeus Nutrition 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 239000013585 weight reducing agent Substances 0.000 description 4
- 208000000044 Amnesia Diseases 0.000 description 3
- 208000031091 Amnestic disease Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000006986 amnesia Effects 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000009519 contusion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000287219 Serinus canaria Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- -1 flavonoids compounds Chemical class 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
一种人参枸杞黄精茶配方及其制备方法，由以下原料制成：益智仁10‑20份，丹凤牡丹花5‑15份，蒲公英10‑20份，栀子10‑20份，人参2‑6份，线叶金雀花5‑15份，玉竹5‑15份，决明子10‑20份，甘草5‑15份，黄精5‑15份，桂圆10‑20份，金银花20‑40份，百合10‑20份，玫瑰5‑15份，桑叶5‑15份，红枣10‑20份，菊花5‑15份，枸杞子10‑20份，金花茶30‑50份。本发明具有减肥降脂、调经止痛、通经活络、消肿散结、补脾益肺、安神益智、润燥、祛风散寒、清热解毒降火、去痰止咳、健胃消食、促进代谢、改善记忆力，改善体质虚弱，能够降低三高、缓解心脑血管等疾病的功效。
Description
技术领域
本发明涉及饮用茶领域，尤其涉及一种人参枸杞黄精茶配方及其制备方法。
背景技术
目前市场上的代用茶大多是一些散户在生产销售,加上市场进入门槛低,所以质量也就很难保证。混合类代用茶是以植物的叶、花、果实、根茎等为原料，按一定比例拼配加工成的产品，并通过小袋包装。目前这种采用植物作为有效成分的代用茶的产品拓宽了传统茶叶口味的局限，更符合现代人的口味和生活习惯，因此具有很广阔的市场前景。本发明所要解决的技术问题是提供一种全新的混合类代用茶产品，以使其具有现代人生活所需的营养、滋补、保健减肥的三重作用，如今有很多对女性身体有害的减肥产品也充斥着市场，让市场鱼龙混杂，事实上，有些产品只是通过腹泻等方式，排出体内水分，从而达到减轻体重的目的，这并不是减肥，而是减水；同时腹泻减肥，容易导致人体营养失衡，产生乏力、厌食等副作用，不值得提倡。随着人们消费观念的改变，科学健康减肥是减肥领域的发展方向，未来市场潜力巨大。
发明内容
针对现有技术中的上述不足，本发明提供了一种人参枸杞黄精茶配方及其制备方法，其制备简单，具有减肥降脂、调经止痛、通经活络、消肿散结、补脾益肺、安神益智、润燥、祛风散寒、清热解毒降火、去痰止咳、健胃消食、促进代谢、改善记忆力，改善体质虚弱，能够降低三高、缓解心脑血管等疾病的功效。
为了达到上述发明目的，本发明采用的具体方案为：
一种人参枸杞黄精茶配方及其制备方法，由以下原料制成：益智仁10-20份，丹凤牡丹花5-15份，蒲公英10-20份，栀子10-20份，人参2-6份，线叶金雀花5-15份，玉竹5-15份，决明子10-20份，甘草5-15份，黄精5-15份，桂圆10-20份，金银花20-40份，百合10-20份，玫瑰5-15份，桑叶5-15份，红枣10-20份，菊花5-15份，枸杞子10-20份，金花茶30-50份。
作为改进，各份原料份数如下：益智仁10份，丹凤牡丹花5份，蒲公英10份，栀子10份，人参2份，线叶金雀花5份，玉竹5份，决明子10份，甘草5份，黄精5份，桂圆10份，金银花20份，百合10份，玫瑰5份，桑叶5份，红枣10份，菊花5份，枸杞子10份，金花茶30份。
作为改进，各份原料份数如下：益智仁15份，丹凤牡丹花10份，蒲公英15份，栀子15份，人参4份，线叶金雀花10份，玉竹10份，决明子15份，甘草10份，黄精10份，桂圆15份，金银花30份，百合15份，玫瑰10份，桑叶10份，红枣15份，菊花10份，枸杞子15份，金花茶40份。
作为改进，各份原料份数如下：益智仁20份，丹凤牡丹花15份，蒲公英20份，栀子20份，人参6份，线叶金雀花15份，玉竹15份，决明子20份，甘草15份，黄精15份，桂圆20份，金银花40份，百合20份，玫瑰15份，桑叶15份，红枣20份，菊花15份，枸杞子20份，金花茶50份。
作为改进，所述人参选择5年及5年以下的人工种植品种。
一种人参枸杞黄精茶配方及其制备方法，其制备方法为：将以上原料经过筛选，将品相不佳和残渣剔除，得到精选后的原料，将精选后的原料放入粉碎机中，以1000-3000转/分钟，进行5-15分钟粉碎，得到粉碎后的原料，将粉碎后的原料放入干燥机中，得到干燥后的原料，将干燥后的原料按照上述份数进行拼配、混合，得到混合均匀的半成品，将混合均匀的半成品放入真空封装机中进行封装，得到成品。
一种人参枸杞黄精茶配方及其制备方法，其饮用方法为：取出成品茶包1袋放入杯子中，加入开水冲泡，3-10分钟后趁热饮用，可反复冲泡直到无色味为止。
益智仁：味辛，性温，归脾、肾经，功效为温脾止泻摄涎，暖肾缩尿固精，主治脾胃虚寒，呕吐，泄泻，腹中冷痛，口多唾涎，肾虚遗尿，尿频，遗精，白浊。
丹凤牡丹花：性平，归人肝、脾二经，能调理气机，疏利肝经，运牌化湿而益气血生化之源，因此能平调妇女经血而止经期腹痛，还可以通经活络。
蒲公英：苦甘，寒，入肝、胃经，清热解毒，利尿散结。治急性乳腺炎，淋巴腺炎，瘰疬，疔毒疮肿，急性结膜炎，感冒发热，急性扁桃体炎，急性支气管炎，胃炎，肝炎，胆囊炎，尿路感染。
栀子：苦，寒，归心、肺、三焦经，功效为泻火除烦，清热利湿，凉血解毒；外用消肿止痛，主治热病心烦，湿热黄疸，淋证涩痛，血热吐衄，目赤肿痛，火毒疮疡，外治扭挫伤痛。
人参：味甘、微苦，性温、平。归脾、肺经、心经，功效为大补元气，复脉固脱，补脾益肺，生津，安神，主治体虚欲脱，肢冷脉微，脾虚食少，肺虚喘咳，津伤口渴，内热消渴，久病虚羸，惊悸失眠，阳痿宫冷；心力衰竭，心原性休克。用于气短喘促，心悸健忘，口渴多汗，食少无力，一切急慢性疾病及失血后引起的休克、虚脱。大补元气，固脱生津，安神。治劳伤虚损，食少，倦怠，反胃吐食，大便滑泄，虚咳喘促，自汗暴脱，惊悸，健忘，眩晕头痛，阳痿，尿频，消渴，妇女崩漏，小儿慢惊，及久虚不复，一切气血津液不足之证。
线叶金雀花：线叶金雀花不含咖啡因和草酸，有镇静中枢神经系统的效果，适合过敏、头痛、睡眠失常、失眠、神经紧张、轻微忧郁症及神经高度紧张等症状的人饮用；线叶金雀花富含的丰富SOD能促进胶原蛋白、弹性蛋白的合成，有利于改善肤质，具有一定的美容效果；线叶金雀花富含的氧化剂(SOD)，能导致体内活性氧等氧化自由基减少，在一定程度上有调节血压降脂软化血管的功效；线叶金雀花具有丰富的营养成分和人体必需的矿物质，长期饮用，有利于牙齿和骨骼的发展；线叶金雀花有缓解皮肤过敏的效果，如果直接敷在受感染的皮肤上，皮肤痒、湿疹、尿布疹、挫疮等皮肤过敏症状都可以在一定程度上得到缓解和减轻；线叶金雀花含有抗氧化(SOD)成分，能减缓氧化作用，有助于维持人体健康并延缓衰老，增强系统免疫能力。
玉竹：养阴润燥，生津止渴，用于肺胃阴伤，燥热咳嗽，咽干口渴，内热消渴。
决明子：味甘、苦，性寒，微咸，归肝、大肠经，功效为清肝明目，润肠通便，用于目赤涩痛，羞明多泪，头痛眩晕，目暗不明，大便秘结。
甘草：味甘，性平，归心、肺、脾、胃经，功效为补脾益气，清热解毒，祛痰止咳，缓急止痛，调和诸药，用于脾胃虚弱，倦怠乏力，心悸气短，咳嗽痰多，脘腹、四肢挛急疼痛，痈肿疮毒，缓解药物毒性、烈性。
黄精：味甘，性平，归脾、肺、肾经，功效为补气养阴，健脾，润肺，益肾，用于脾胃气虚，体倦乏力，胃阴不足，口干食少，肺虚燥咳，劳嗽咳血，精血不足，腰膝酸软，须发早白，内热消渴。
桂圆：性温，味甘，具有补益心脾、养血安神的功能。主治气血不足、心悸不宁、健忘失眠、血虚萎黄等症，以及中老年虚弱、高血压、高血脂和冠心病等。
金银花：性甘、寒，归肺、胃经，功效为清热解毒，消炎退肿，主治外感风热或温病发热，中暑，热毒血痢，痈肿疔疮，喉痹，多种感染性疾病。
百合：味甘，性寒，归心、肺经，功效为养阴润肺，清心安神，用于阴虚燥咳，劳嗽咳血，虚烦惊悸，失眠多梦，精神恍惚。
玫瑰：甘、微苦，温，归肝、脾经，功效为行气解郁，和血，止痛，用于肝胃气痛，食少呕恶，月经不凋，跌扑伤痛。
桑叶：味苦、甘，性寒，归肺、肝经，功效为疏散风热，清肺润燥，平肝明目，凉血止血，风热感冒，温病初起，肺热咳嗽，肝阳上亢眩晕，目赤昏花，血热妄行之咳血、吐血。
红枣：性温、味甘，具益气补血、健脾和胃、袪风功效，对治疗过敏性紫癜、贫血、高血压、急慢性肝炎和肝硬化患者的血清转氨酶增高，以及预防输血反应等均有理想效果；大枣含有三萜类化合物及环磷酸腺苷，有较强的抑癌、抗过敏作用。枣中含有抗疲劳作用的物质，能增强人的耐力，枣还具有减轻毒性物质对肝脏损害的功效。枣中的黄酮类化合物，有镇静降血压的作用。
菊花：味苦、甘，性微寒，归肺、肝经，功效为散风清热，平肝明目，清热解毒。
枸杞子：甘，平，入肝、肾经，具有滋肾，润肺，补肝，明目。治肝肾阴亏，腰膝酸软，头晕，目眩，目昏多泪，虚劳咳嗽，消渴，遗精。
金花茶：花茶属无毒级、含有400多种营养物质、无毒副作用。富含茶多糖、茶多酚、总皂甙、总黄酮、茶色素、咖啡因、蛋白质、维生素B1、B2、维生素C、维生素E、叶酸、脂肪酸、B-胡萝卜素等多种天然营养成份；金花茶含有茶氨酸、苏氨酸等几十种氨基酸，以及富含有多种对人体具有重要保健作用的天然有机锗(Ge)、硒(Se)、钼(Mo)、锌(Zn)、钒(V)等微量元素，和钾(K)、钙(Ca)、镁(Mg)等宏量元素，金花茶具有明显的降血糖和尿糖作用，能有效的改善糖尿病“三高”症状。金花茶在有效降低血糖、血压的同时，可有效降低血脂，改善因高血压而引起的各种不适应症状，降低血清中胆固醇和B-脂蛋白，促进胰岛素分泌、增强免疫力、调节血流量，防止动脉粥样硬化，抗菌消炎、清热解毒、通便利尿去湿，增进肝脏代谢、防癌抑制肿瘤生长等，金花茶对降血糖、降血压、降血脂、降胆固醇,对糖尿病及其并发症有独特神奇的功效，起协同平衡调节作用。
本发明的有益效果为：
本发明具有减肥降脂、调经止痛、通经活络、消肿散结、补脾益肺、安神益智、润燥、祛风散寒、清热解毒降火、去痰止咳、健胃消食、促进代谢、改善记忆力，改善体质虚弱，能够降低三高、缓解心脑血管等疾病的功效。
具体实施方式
以下通过具体实施例进一步描述本发明，但本发明不仅仅限于以下实施例。在本发明的范围内或者在不脱离本发明的内容、精神和范围内，对本发明进行的变更、组合或替换，对于本领域的技术人员来说是显而易见的，且包含在本发明的范围之内。
实施例一
一种人参枸杞黄精茶配方及其制备方法，各份原料份数如下：益智仁10份，丹凤牡丹花5份，蒲公英10份，栀子10份，人参2份，线叶金雀花5份，玉竹5份，决明子10份，甘草5份，黄精5份，桂圆10份，金银花20份，百合10份，玫瑰5份，桑叶5份，红枣10份，菊花5份，枸杞子10份，金花茶30份。
其制备方法为：将以上原料经过筛选，将品相不佳和残渣剔除，得到精选后的原料，将精选后的原料放入粉碎机中，以1000转/分钟，进行5分钟粉碎，得到粉碎后的原料，将粉碎后的原料放入干燥机中，得到干燥后的原料，将干燥后的原料按照上述份数进行拼配、混合，得到混合均匀的半成品，将混合均匀的半成品放入真空封装机中进行封装，得到成品。
取出成品茶包1袋放入杯子中，加入开水冲泡，3分钟后趁热饮用，可反复冲泡直到无色味为止。
实施例二
一种人参枸杞黄精茶配方及其制备方法，各份原料份数如下：益智仁15份，丹凤牡丹花10份，蒲公英15份，栀子15份，人参4份，线叶金雀花10份，玉竹10份，决明子15份，甘草10份，黄精10份，桂圆15份，金银花30份，百合15份，玫瑰10份，桑叶10份，红枣15份，菊花10份，枸杞子15份，金花茶40份。
其制备方法为：将以上原料经过筛选，将品相不佳和残渣剔除，得到精选后的原料，将精选后的原料放入粉碎机中，以2000转/分钟，进行10分钟粉碎，得到粉碎后的原料，将粉碎后的原料放入干燥机中，得到干燥后的原料，将干燥后的原料按照上述份数进行拼配、混合，得到混合均匀的半成品，将混合均匀的半成品放入真空封装机中进行封装，得到成品。
取出成品茶包1袋放入杯子中，加入开水冲泡，6分钟后趁热饮用，可反复冲泡直到无色味为止。
实施例三
一种人参枸杞黄精茶配方及其制备方法，各份原料份数如下：益智仁20份，丹凤牡丹花15份，蒲公英20份，栀子20份，人参6份，线叶金雀花15份，玉竹15份，决明子20份，甘草15份，黄精15份，桂圆20份，金银花40份，百合20份，玫瑰15份，桑叶15份，红枣20份，菊花15份，枸杞子20份，金花茶50份。
其制备方法为：将以上原料经过筛选，将品相不佳和残渣剔除，得到精选后的原料，将精选后的原料放入粉碎机中，以3000转/分钟，进行15分钟粉碎，得到粉碎后的原料，将粉碎后的原料放入干燥机中，得到干燥后的原料，将干燥后的原料按照上述份数进行拼配、混合，得到混合均匀的半成品，将混合均匀的半成品放入真空封装机中进行封装，得到成品。
取出成品茶包1袋放入杯子中，加入开水冲泡，10分钟后趁热饮用，可反复冲泡直到无色味为止
以上所述仅为本发明专利的较佳实施例而已，并不用以限制本发明专利，凡在本发明专利的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明专利的保护范围之内。
Claims (7)
1.一种人参枸杞黄精茶配方及其制备方法，其特征在于：由以下原料制成：益智仁10-20份，丹凤牡丹花5-15份，蒲公英10-20份，栀子10-20份，人参2-6份，线叶金雀花5-15份，玉竹5-15份，决明子10-20份，甘草5-15份，黄精5-15份，桂圆10-20份，金银花20-40份，百合10-20份，玫瑰5-15份，桑叶5-15份，红枣10-20份，菊花5-15份，枸杞子10-20份，金花茶30-50份。
2.根据权利要求1所述的一种人参枸杞黄精茶配方及其制备方法，其特征在于：各份原料份数如下：益智仁10份，丹凤牡丹花5份，蒲公英10份，栀子10份，人参2份，线叶金雀花5份，玉竹5份，决明子10份，甘草5份，黄精5份，桂圆10份，金银花20份，百合10份，玫瑰5份，桑叶5份，红枣10份，菊花5份，枸杞子10份，金花茶30份。
3.据权利要求1所述的一种人参枸杞黄精茶配方及其制备方法，其特征在于：各份原料份数如下：益智仁15份，丹凤牡丹花10份，蒲公英15份，栀子15份，人参4份，线叶金雀花10份，玉竹10份，决明子15份，甘草10份，黄精10份，桂圆15份，金银花30份，百合15份，玫瑰10份，桑叶10份，红枣15份，菊花10份，枸杞子15份，金花茶40份。
4.据权利要求1所述的一种人参枸杞黄精茶配方及其制备方法，其特征在于：各份原料份数如下：益智仁20份，丹凤牡丹花15份，蒲公英20份，栀子20份，人参6份，线叶金雀花15份，玉竹15份，决明子20份，甘草15份，黄精15份，桂圆20份，金银花40份，百合20份，玫瑰15份，桑叶15份，红枣20份，菊花15份，枸杞子20份，金花茶50份。
5.据权利要求1所述的一种人参枸杞黄精茶配方及其制备方法，其特征在于：所述人参选择5年及5年以下的人工种植品种。
6.据权利要求1所述的一种人参枸杞黄精茶配方及其制备方法，其特征在于：其制备方法为：将以上原料经过筛选，将品相不佳和残渣剔除，得到精选后的原料，将精选后的原料放入粉碎机中，以1000-3000转/分钟，进行5-15分钟粉碎，得到粉碎后的原料，将粉碎后的原料放入干燥机中，得到干燥后的原料，将干燥后的原料按照上述份数进行拼配、混合，得到混合均匀的半成品，将混合均匀的半成品放入真空封装机中进行封装，得到成品。
7.据权利要求6所述的一种人参枸杞黄精茶配方及其制备方法，其特征在于：其饮用方法为：取出成品茶包1袋放入杯子中，加入开水冲泡，3-10分钟后趁热饮用，可反复冲泡直到无色味为止。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010427281.4A CN113678922A (zh) | 2020-05-19 | 2020-05-19 | 一种人参枸杞黄精茶配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010427281.4A CN113678922A (zh) | 2020-05-19 | 2020-05-19 | 一种人参枸杞黄精茶配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113678922A true CN113678922A (zh) | 2021-11-23 |
Family
ID=78575997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010427281.4A Pending CN113678922A (zh) | 2020-05-19 | 2020-05-19 | 一种人参枸杞黄精茶配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113678922A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114403329A (zh) * | 2022-02-28 | 2022-04-29 | 浙江农林大学 | 一种具有抗氧化功能的复方饮料及其制备方法 |
| CN114747643A (zh) * | 2022-05-10 | 2022-07-15 | 上海云梯医药科技有限公司 | 一种养生参茶及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343113A (zh) * | 2016-11-02 | 2017-01-25 | 东方福尚福养生有限公司 | 一种人参养生保健美容茶及其制备方法 |
| CN110637911A (zh) * | 2019-11-14 | 2020-01-03 | 罗贤义 | 一种参花果叶椹康茶制备方法 |
| CN111110792A (zh) * | 2020-01-17 | 2020-05-08 | 杨波 | 一种控糖调脂降粘防治糖尿病及其并发症的黄精人参茶 |
-
2020
- 2020-05-19 CN CN202010427281.4A patent/CN113678922A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343113A (zh) * | 2016-11-02 | 2017-01-25 | 东方福尚福养生有限公司 | 一种人参养生保健美容茶及其制备方法 |
| CN110637911A (zh) * | 2019-11-14 | 2020-01-03 | 罗贤义 | 一种参花果叶椹康茶制备方法 |
| CN111110792A (zh) * | 2020-01-17 | 2020-05-08 | 杨波 | 一种控糖调脂降粘防治糖尿病及其并发症的黄精人参茶 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114403329A (zh) * | 2022-02-28 | 2022-04-29 | 浙江农林大学 | 一种具有抗氧化功能的复方饮料及其制备方法 |
| CN114747643A (zh) * | 2022-05-10 | 2022-07-15 | 上海云梯医药科技有限公司 | 一种养生参茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104940606A (zh) | 调理八种偏颇体质的鹿胶保健品 | |
| CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
| CN102698117A (zh) | 一种生发中药制剂的配方及制备方法 | |
| CN104586669A (zh) | 一种减肥外用霜 | |
| CN106860680A (zh) | 金花人参压片糖果及其制备方法 | |
| KR20020029455A (ko) | 두피건강 및 강정식품의 제조방법 | |
| CN113678922A (zh) | 一种人参枸杞黄精茶配方及其制备方法 | |
| CN106085683A (zh) | 一种具有保健功效的sod葡萄酒 | |
| CN112167574A (zh) | 一种新鲜龟苓膏及其制备方法 | |
| KR101065799B1 (ko) | 천일염을 이용한 입욕제의 제조방법 | |
| CN106343091A (zh) | 一种减肥瘦身茶凉茶饮料及其制备方法 | |
| CN105532991A (zh) | 一种具有养颜美容功能的复合黑茶及其制备方法 | |
| KR101281059B1 (ko) | 삼푸조성물 및 그 제조 방법 | |
| CN105708970A (zh) | 一种具有降血糖功能的保健食品 | |
| CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
| CN110839800A (zh) | 一种药食同源的富硒微量元素植物营养饮品及制备方法 | |
| CN106417761A (zh) | 一种玫瑰养颜美人茶凉茶饮料及其制备方法 | |
| CN102698118A (zh) | 一种乌发中药制剂的配方及制备方法 | |
| CN110680794A (zh) | 一种纯天然无化学添加剂的食品级珍珠蜂蜜茶味口腔护理组合物的绿色制备方法及其应用 | |
| CN111388639B (zh) | 用于缓解绝经综合症的苯乙醇苷和异黄酮提取物及应用 | |
| CN114522213A (zh) | 一种改善记忆力的草本雾化组合物及其制备方法 | |
| CN106344480A (zh) | 一种美白祛斑无毒副作用的中药面膜及其制备方法 | |
| CN107149014A (zh) | 一种适合失眠人群饮用的凉茶饮料及其制备方法 | |
| CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
| CN105106085A (zh) | 凹凸棒中草药防晒霜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |